Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs.
cervical cancer
human papillomavirus
therapeutic vaccines
vaccines
viral cancers
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
06
2022
accepted:
04
08
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
1
10
2022
Statut:
epublish
Résumé
Human papillomavirus (HPV) contributes to sexually transmitted infection, which is primarily associated with pre-cancerous and cancerous lesions in both men and women and is among the neglected cancerous infections in the world. At global level, two-, four-, and nine-valent pure L1 protein encompassed vaccines in targeting high-risk HPV strains using recombinant DNA technology are available. Therapeutic vaccines are produced by early and late oncoproteins that impart superior cell immunity to preventive vaccines that are under investigation. In the current review, we have not only discussed the clinical significance and importance of both preventive and therapeutic vaccines but also highlighted their dosage and mode of administration. This review is novel in its way and will pave the way for researchers to address the challenges posed by HPV-based vaccines at the present time.
Identifiants
pubmed: 36176419
doi: 10.3389/fonc.2022.977933
pmc: PMC9513379
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
977933Informations de copyright
Copyright © 2022 Bhattacharjee, Kumar, Dhasmana, Mitra, Dey, Malik, Kim and Gundamaraju.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Rev Cancer. 2018 Apr;18(4):240-254
pubmed: 29497146
Antiviral Res. 2016 Jun;130:101-9
pubmed: 27040313
Oncoimmunology. 2019 Jan 17;8(4):e1560919
pubmed: 30906653
Vaccine. 2020 Jan 3;38(1):39-45
pubmed: 31611099
Cochrane Database Syst Rev. 2019 Nov 22;2019(11):
pubmed: 31755549
J Virol. 2018 Mar 28;92(8):
pubmed: 29437968
mBio. 2021 Jan 19;12(1):
pubmed: 33468698
Vaccine. 2013 Jul 25;31(34):3452-60
pubmed: 23770335
J Natl Cancer Inst. 2015 Oct 14;108(1):
pubmed: 26467666
Sci Transl Med. 2012 Oct 10;4(155):155ra138
pubmed: 23052295
Clin Cancer Res. 2002 May;8(5):1028-37
pubmed: 12006515
Cancer Lett. 2020 Feb 28;471:88-102
pubmed: 31812696
Lancet. 2009 Jul 25;374(9686):301-14
pubmed: 19586656
Int J Cancer. 2000 Jun 1;86(5):725-30
pubmed: 10797297
Clin Cancer Res. 2004 May 1;10(9):2954-61
pubmed: 15131030
Virology. 1991 Nov;185(1):251-7
pubmed: 1656586
PLoS Pathog. 2014 Aug 07;10(8):e1004254
pubmed: 25101974
Vaccine. 2018 Aug 6;36(32 Pt A):4768-4773
pubmed: 29325819
Cancer Prev Res (Phila). 2013 Nov;6(11):1242-50
pubmed: 24189371
Gynecol Oncol. 2017 Jul;146(1):196-204
pubmed: 28442134
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Mar;39(2):165-8
pubmed: 18630674
J Transl Med. 2015 Mar 05;13:80
pubmed: 25763880
J Obstet Gynaecol Res. 2018 Jun;44(6):989-997
pubmed: 29517117
Vaccines (Basel). 2020 Jul 16;8(3):
pubmed: 32708759
JAMA Netw Open. 2019 Oct 2;2(10):e1914031
pubmed: 31651968
Lancet Oncol. 2012 Jan;13(1):89-99
pubmed: 22075171
Int J Cancer. 1988 Jan 15;41(1):41-5
pubmed: 2826346
Br J Cancer. 2010 Mar 30;102(7):1129-36
pubmed: 20234368
Int Immunopharmacol. 2019 Apr;69:279-288
pubmed: 30743204
Expert Rev Vaccines. 2016 Aug;15(8):989-1007
pubmed: 26901118
Clin Infect Dis. 2016 Aug 15;63(4):519-27
pubmed: 27230391
N Engl J Med. 2009 Nov 5;361(19):1838-47
pubmed: 19890126
Oncoimmunology. 2015 May 27;4(10):e1029699
pubmed: 26451295
J Mol Endocrinol. 2019 May;62(4):R269-R287
pubmed: 30870810
Curr Top Med Chem. 2012;12(14):1581-92
pubmed: 22827526
J Natl Cancer Inst. 2020 Oct 1;112(10):1030-1037
pubmed: 32091596
Front Immunol. 2020 Feb 18;11:188
pubmed: 32133000
Braz J Infect Dis. 2014 Nov-Dec;18(6):651-9
pubmed: 24780368
Mol Cell. 2000 Mar;5(3):557-67
pubmed: 10882140
Am J Obstet Gynecol. 2003 Apr;188(4):916-26
pubmed: 12712086
Clin Infect Dis. 2018 Oct 15;67(9):1339-1346
pubmed: 29659751
J Clin Virol. 2005 Mar;32 Suppl 1:S7-15
pubmed: 15753007
N Engl J Med. 2015 Feb 19;372(8):711-23
pubmed: 25693011
Vaccine. 2001 Jul 16;19(28-29):3936-9
pubmed: 11427268
Medicine (Baltimore). 2021 Oct 15;100(41):e27457
pubmed: 34731120
Gene Ther. 2011 Mar;18(3):304-12
pubmed: 20981112
Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791
pubmed: 29551226
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancer Immunol Immunother. 2012 Sep;61(9):1485-92
pubmed: 22684521
Gynecol Oncol. 2020 Feb;156(2):503-510
pubmed: 31870557
Front Public Health. 2021 Jan 20;8:552028
pubmed: 33553082
Sci Transl Med. 2014 Jan 29;6(221):221ra13
pubmed: 24477000
Cancer Immunol Immunother. 2016 May;65(5):563-73
pubmed: 26980480
Hum Vaccin Immunother. 2016 Jun 2;12(6):1352-6
pubmed: 26901390
Int J Oncol. 2019 Sep;55(3):570-584
pubmed: 31364734
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Clin Infect Dis. 2018 Jan 18;66(3):339-345
pubmed: 29029053
Lancet Infect Dis. 2012 Oct;12(10):781-9
pubmed: 22920953
Int J Biol Sci. 2021 Jul 13;17(11):2944-2956
pubmed: 34345218
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
J Community Health. 2013 Oct;38(5):907-10
pubmed: 23653161
Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:59-72
pubmed: 29108943
Cancer Immunol Immunother. 2014 Feb;63(2):147-60
pubmed: 24233343
Environ Sci Pollut Res Int. 2021 Sep;28(35):47752-47772
pubmed: 34291408
Postepy Hig Med Dosw (Online). 2015 Apr 28;69:543-8
pubmed: 25983293
Front Immunol. 2021 Sep 30;12:645299
pubmed: 34659195
Lancet. 2017 Nov 11;390(10108):2143-2159
pubmed: 28886907
Int J Oncol. 2004 Jan;24(1):161-7
pubmed: 14654953
Lancet. 2007 Jun 30;369(9580):2161-2170
pubmed: 17602732
J Infect Dis. 2009 Mar 15;199(6):805-14
pubmed: 19199546
Crit Rev Oncol Hematol. 2022 Sep;177:103753
pubmed: 35803452
Crit Rev Oncol Hematol. 2022 Jun;174:103675
pubmed: 35381343
Hum Vaccin Immunother. 2019;15(1):141-145
pubmed: 30261146
Hum Vaccin Immunother. 2016 Jun 2;12(6):1418-29
pubmed: 26835746
Vaccine. 2002 Oct 4;20(29-30):3456-64
pubmed: 12297390
Cancer Immunol Immunother. 2015 Mar;64(3):367-79
pubmed: 25537079
Curr Probl Cancer. 2018 Sep;42(5):493-506
pubmed: 30041818
Obstet Gynecol. 2004 Feb;103(2):317-26
pubmed: 14754702
Eur J Cancer Prev. 2003 Oct;12(5):383-90
pubmed: 14512803
Expert Rev Vaccines. 2015;14(11):1509-23
pubmed: 26313239
Gynecol Oncol. 2016 Feb;140(2):245-52
pubmed: 26616223
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12180-4
pubmed: 1334560
F1000Res. 2017 Jun 12;6:866
pubmed: 28663791
Gynecol Oncol. 2006 Mar;100(3):469-78
pubmed: 16249018
Hum Vaccin. 2011 Dec;7(12):1374-86
pubmed: 22048171
Cancer Discov. 2011 Oct;1(5):408-19
pubmed: 22586631
Gynecol Oncol. 2009 Sep;114(3):501-5
pubmed: 19541348
Gynecol Oncol. 2020 Feb;156(2):498-502
pubmed: 31848025
N Engl J Med. 2011 Feb 3;364(5):401-11
pubmed: 21288094
J Natl Cancer Inst. 2018 Feb 1;110(2):
pubmed: 28954299
Hum Vaccin. 2009 Oct;5(10):696-704
pubmed: 19855170
Arch Med Res. 2014 Oct;45(7):525-39
pubmed: 25450584
Nat Rev Clin Oncol. 2022 May;19(5):306-327
pubmed: 35105976
Acad Pediatr. 2018 Mar;18(2S):S3-S10
pubmed: 29502635
J Obstet Gynaecol Res. 2020 Jul;46(7):989-1006
pubmed: 32390320
Lancet Oncol. 2015 Jul;16(7):775-86
pubmed: 26071347
Vaccine. 2004 Jul 29;22(21-22):2722-9
pubmed: 15246603
Vaccine. 2009 Jun 19;27(30):3975-83
pubmed: 19389451
J Formos Med Assoc. 2010 Jul;109(7):481-3
pubmed: 20677402
JAMA. 2013 May 1;309(17):1793-802
pubmed: 23632723
Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:2-13
pubmed: 28964706
J Transl Med. 2013 Apr 04;11:88
pubmed: 23557172
Acta Cytol. 2019;63(2):159-168
pubmed: 30870844
J Biomed Sci. 2016 Nov 04;23(1):75
pubmed: 27809842
Immunotargets Ther. 2020 Oct 07;9:167-200
pubmed: 33117742
Virology. 2018 Dec;525:205-215
pubmed: 30296681
Oncoimmunology. 2015 May 27;4(10):e1031439
pubmed: 26451301
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):113-128
pubmed: 26004498
Vaccine. 2010 Jul 19;28(32):5212-9
pubmed: 20541583
Eur J Cancer Prev. 2014 May;23(3):206-24
pubmed: 24129107
J Biomed Sci. 2010 Nov 22;17:88
pubmed: 21092195
Vaccine. 2008 Jun 19;26(26):3197-208
pubmed: 18486285
Vaccine. 2007 Dec 5;25(50):8352-8
pubmed: 17996990
Nat Commun. 2014 Oct 30;5:5317
pubmed: 25354725
Biomed Pharmacother. 2022 Sep;153:113345
pubmed: 35810692
Clin Cancer Res. 2016 Jul 1;22(13):3238-48
pubmed: 27252412
Can Fam Physician. 2016 May;62(5):399-402
pubmed: 27255620
Gynecol Oncol. 2019 Jul;154(1):110-117
pubmed: 30982556
Transl Res. 2016 Feb;168:74-95
pubmed: 26297944
Cancer Sci. 2007 Oct;98(10):1505-11
pubmed: 17645777
J Virol. 2008 Feb;82(4):1968-79
pubmed: 18057249
Sex Transm Dis. 2014 Nov;41(11):660-4
pubmed: 25299412
Arch Pharm Res. 2017 Sep;40(9):1050-1063
pubmed: 28875439
Vaccine. 2018 Jul 16;36(30):4462-4470
pubmed: 29914845
Lancet. 2015 Nov 21;386(10008):2078-2088
pubmed: 26386540
Indian J Med Res. 2009 Sep;130(3):296-310
pubmed: 19901439
Infect Agent Cancer. 2010 Oct 20;5:19
pubmed: 20961432
J Clin Pathol. 2005 Sep;58(9):946-50
pubmed: 16126875
Sci Transl Med. 2016 Apr 13;8(334):334ra52
pubmed: 27075626
PLoS One. 2013 May 01;8(5):e61825
pubmed: 23650505
Immunol Rev. 2010 Jul;236:125-38
pubmed: 20636813
Hum Vaccin Immunother. 2019;15(7-8):1970-1979
pubmed: 31268383
PLoS One. 2013 Jul 17;8(7):e68329
pubmed: 23873171
Front Immunol. 2018 Dec 19;9:3000
pubmed: 30619353
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Pediatrics. 2017 Dec;140(6):
pubmed: 29167376
Trends Microbiol. 2018 Feb;26(2):158-168
pubmed: 28823569
Mol Ther. 2021 Feb 3;29(2):611-625
pubmed: 33160073
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:109-124
pubmed: 32284298
Epidemiol Infect. 2016 Feb;144(3):449-68
pubmed: 26429676
N Engl J Med. 2004 Nov 25;351(22):2286-94
pubmed: 15525713
Expert Rev Vaccines. 2016 Oct;15(10):1327-36
pubmed: 27063030
J Transl Med. 2014 Dec 16;12:353
pubmed: 25510844
BMC Cancer. 2018 Jan 30;18(1):112
pubmed: 29382323
Curr Opin Immunol. 2017 Aug;47:17-25
pubmed: 28728074
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
Front Immunol. 2021 Mar 09;12:636568
pubmed: 33767702